New Product Launch Impact
Enterprise growth from recent product launches to stabilize revenue with potential 10-15% sequential improvement
Impact: +₹7.15 Cr revenue
“Q3 FY26 saw strong enterprise growth mentioned in TradingView report”
Quick Heal Technologies Ltd (IT - Software) — fundamental analysis, earnings data, and key metrics. PE: 125.0. ROE: 0.6%. This stock is not currently in the Nifty 500 momentum outperformers list.
Deep value thesis based on recent earnings • Updated Feb 22, 2026
Debt-free balance sheet and management overhaul provide foundation for turnaround, but core business remains unprofitable without non-operational income support.
Verdict
EARLY_INNINGS
Re-rating catalysts over the next 2-4 quarters • Updated Feb 22, 2026
Enterprise growth from recent product launches to stabilize revenue with potential 10-15% sequential improvement
Impact: +₹7.15 Cr revenue
“Q3 FY26 saw strong enterprise growth mentioned in TradingView report”
Evidence of new leadership team driving sustainable margin expansion beyond 5% OPM
“New senior management appointments in January 2026 board meeting”
Resolution of deteriorating debtors turnover ratio (1.57x in H1 FY26) to improve cash flow
“Debtors turnover ratio deteriorated to 1.57x in H1 FY26 per MarketsMojo analysis”
Potential FII re-entry after stake collapse from 2.02% to 0.45% in three quarters
“FII holding collapsed from 2.02% to 0.45% in three quarters per MarketsMojo”
Risks that could prevent re-rating or deepen the value trap
Reduction in other income sources
Impact: -500 bps margin impact
Management view: Company acknowledges need to improve core operations per management commentary in Q3 results
Monitor: Other income as % of PBT
Continued erratic quarterly performance
Impact: -300 bps margin impact
Management view: Management cites market challenges but lacks clear strategy for stabilization
Monitor: QoQ revenue growth consistency
Accelerated market shift to cloud-based security solutions
Impact: -1000 bps margin impact
Management view: New product launches indicate awareness but execution remains unproven
Monitor: Enterprise segment growth rate
Forward-looking targets from management for FY27
Key Milestones
• Sustainable OPM above 5%
• Consistent quarterly revenue growth
• Enterprise segment contribution >40% of total revenue
The above analysis is AI-generated from publicly available financial data. This is educational research only — not investment advice. Last updated Feb 22, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Quick Heal Technologies Ltd's latest quarterly results (Dec 2025) show
Quick Heal Technologies Ltd's current PE ratio is 125.0x.
Quick Heal Technologies Ltd's price-to-book ratio is 1.6x.
Quick Heal Technologies Ltd's fundamental strength based on key financial ratios
Quick Heal Technologies Ltd has a debt-to-equity ratio of N/A.
Quick Heal Technologies Ltd's return ratios over recent years
Quick Heal Technologies Ltd's operating cash flow is negative (FY2025).
Quick Heal Technologies Ltd currently does not pay a significant dividend (yield 0.00%).
Quick Heal Technologies Ltd's shareholding pattern (Dec 2025)
Quick Heal Technologies Ltd's promoter holding has decreased recently.
Quick Heal Technologies Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Quick Heal Technologies Ltd has 4 key growth catalysts identified from recent earnings analysis
Quick Heal Technologies Ltd has 3 key risks worth monitoring
Quick Heal Technologies Ltd's management has provided the following forward guidance for FY27
Based on quantitative research signals, here is why Quick Heal Technologies Ltd may be worth studying
Quick Heal Technologies Ltd investment thesis summary:
Quick Heal Technologies Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.